2-47799299-A-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The ENST00000234420.11(MSH6):c.1316A>G(p.Asp439Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D439Y) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000234420.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH6 | NM_000179.3 | c.1316A>G | p.Asp439Gly | missense_variant | 4/10 | ENST00000234420.11 | NP_000170.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH6 | ENST00000234420.11 | c.1316A>G | p.Asp439Gly | missense_variant | 4/10 | 1 | NM_000179.3 | ENSP00000234420 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2020 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in an individual with constitutional mismatch repair deficiency syndrome, and several individuals affected with Lynch syndrome (PMID: 30013564, Invitae). ClinVar contains an entry for this variant (Variation ID: 185673). This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with glycine at codon 439 of the MSH6 protein (p.Asp439Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2024 | The p.D439G variant (also known as c.1316A>G), located in coding exon 4 of the MSH6 gene, results from an A to G substitution at nucleotide position 1316. The aspartic acid at codon 439 is replaced by glycine, an amino acid with similar properties. This alteration is identified in an individual whose colorectal tumor was microsatellite stable and demonstrated normal mismatch repair protein expression on immunohistochemistry (IHC); however, this alteration is also identified in individuals whose Lynch-related tumors demonstrated high microsatellite instability and/or loss of MSH6 expression on IHC, and in an individual whose colorectal tumor was microsatellite stable but demonstrated loss of MSH6 expression on IHC (Ambry internal data). This alteration is identified in conjunction with a pathogenic alteration in MSH6 (phase unknown) in a four year-old male with clinical features consistent with CMMRD (Tesch VK et al. Front Immunol, 2018 Jul;9:1506). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at